![John Boniface](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Boniface
Chief Tech/Sci/R&D Officer at
SERA PROGNOSTICS, INC.
Net worth: 239 244 $ as of 31/05/2026
Profile
John J.
Boniface is currently Chief Scientific Officer at Sera Prognostics, Inc., a position held since 2011.
Formerly, Dr. Boniface was Program Director at Myriad Genetics, Inc., Myrexis, Inc., EOS Biotechnology, Inc., and Prolexys Pharmaceuticals, Inc., and Vice President-Science at Bioinformatics Solutions, Inc. Education includes undergraduate studies at the University of Massachusetts and a doctorate from Albany Medical College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/04/2026 | 110,761 ( 0.29% ) | 239 244 $ | 31/05/2026 |
John Boniface active positions
| Companies | Position | Start |
|---|---|---|
| SERA PROGNOSTICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2011 |
Former positions of John Boniface
| Companies | Position | End |
|---|---|---|
Bioinformatics Solutions, Inc.
 Bioinformatics Solutions, Inc. Packaged SoftwareTechnology Services Provides bioinformatics analysis software and services | Chief Tech/Sci/R&D Officer | - |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Corporate Officer/Principal | - |
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | - |
Prolexys Pharmaceuticals, Inc.
 Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
| MYREXIS, INC. | Corporate Officer/Principal | - |
Training of John Boniface
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Myrexis, Inc.
 Myrexis, Inc. Financial ConglomeratesFinance Engages in identifying, evaluating and making financial investments in life sciences assets | Finance |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Albany Medical College
 Albany Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sera Prognostics, Inc.
 Sera Prognostics, Inc. Medical/Nursing ServicesHealth Services Provides personalized diagnostics to predict and manage pregnancy complications | Health Services |
Bioinformatics Solutions, Inc.
Bioinformatics Solutions, Inc. Packaged SoftwareTechnology Services Provides bioinformatics analysis software and services | Technology Services |
- Stock Market
- Insiders
- John Boniface
